fmoc-gabapentin,
882847-19-0,
(1-[(9h-fluoren-9-ylmethoxycarbonylamino)-methyl]-cyclohexyl)-acetic acid,
2-[1-[(9H-fluoren-9-ylmethoxycarbonylamino)methyl]cyclohexyl]acetic Acid,
Cyclohexaneacetic acid,1-[[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]methyl]-,
(1-[(9h-fluoren-9-ylmethoxycarbonylamino)methyl]cyclohexyl)acetic acid,
{1-[(9H-Fluoren-9-ylmethoxycarbonylamino)methyl]cyclohexyl}acetic acid,
{1-[(9H-Fluoren-9-ylmethoxycarbonylamino)-methyl]-cyclohexyl}-acetic acid,
2-(1-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)methyl)cyclohexyl)acetic acid,
[1-[(9h-fluoren-9-ylmethoxycarbonylamino)-methyl]-cyclohexyl]-acetic acid,
2-{1-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]cyclohexyl}acetic acid,
AC1MBSSF,
CTK5F9578,
DTXSID30373234,
ZINC2541363,
4187AH,
MFCD04973795,
AKOS012711600,
AS-40647,
DB-016977,
RT-012961,
FT-0759417,
[1-((Fmoc-amino)methyl)cyclohexyl]acetic acid,
A-7873,
Z2445728905,
(1-[(9H-fluoren-9-ylmethoxycarbonylamino)methyl]cyclohexyl)acetic acid AldrichCPR,
(1-[(9H-fluoren-9-ylmethoxycarbonylamino)methyl]cyclohexyl)acetic acid, AldrichCPR,
2-(1-((((9H-fluoren-9-yl)methoxy)carbonylamino)methyl)cyclohexyl)acetic acid,
C24H27NO4,
CID2756095,